Nostrum Laboratories Inc Recall: Metformin Hydrochloride Extended-Release Tablets, USP, 75
Nostrum Laboratories Inc Recall: Metformin Hydrochloride Extended-Release Tablets, USP, 75 is one of 9,000 recalls in the RecallGuard dataset. Key details — Recalling firm: Nostrum Laboratories Inc; Product: Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 Tablets per bottle, Rx Only, Manufactured by:
| Recalling firm | Nostrum Laboratories Inc |
|---|---|
| Product | Metformin Hydrochloride Extended-Release Tablets, USP, 750 mg, 100 Tablets per bottle, Rx Only, Manufactured by: Nostrum Laboratories, Inc., Kansas City, MO 64120. NDC: 29033-056-01 |
| Reason for recall | CGMP Deviations: detection of N-Nitrosodimethylamine (NDMA) impurity above the acceptable intake level. |
| Classification | Class II (moderate — may cause temporary or reversible health consequences) |
| Status | Ongoing |
| Distribution | Nationwide |
| Recall initiated | 20210125 |
| Recall number | D-0249-2021 |
| Category | drug |
| State | MO |
| Country | United States |
$29/mo
Try RecallGuard →